Deutsche Post AG

  • WKN: 555200
  • ISIN: DE0005552004
  • Land: Germany

Nachricht vom 07.10.2021 | 15:12

Deutsche Post AG sees strong Q3 2021 and will raise guidance

Deutsche Post AG / Key word(s): Quarter Results/Change in Forecast
Deutsche Post AG sees strong Q3 2021 and will raise guidance

07-Oct-2021 / 15:12 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Deutsche Post AG sees strong Q3 2021 and will raise guidance


Disclosure of inside information pursuant to Article 17 MAR

Management has today assessed the preliminary group results for the month of September and hence Q3 2021 as well as the outlook for the remainder of the year.

The positive development of the group's businesses seen in the first half of the year has continued well through the third quarter 2021. Q3 volume trends confirm base assumptions with continued well supported B2B recovery and B2C volumes staying at high previous year levels across all major networks. At the same time the tight capacity situation both in Ocean and Air Freight markets continued. For Q3 2021 the EBIT performance is forming out as follows:

Preliminary group EBIT reached around EUR 1.765 billion in Q3 2021 (Q3 2020: EUR 1.377 billion), bringing the EBIT of the first nine months of this year to around EUR 5.760 billion. As a reminder, Q3 2020 came including EUR -163 million for the one-time pandemic bonus; in this year's Q3 there is an effect of EUR -179 million with a similar distribution across the divisions. Related payment is expected in Q4.

The divisional results in Q3 in detail:

EBIT in the Express division reached around EUR 970 million in the third quarter of 2021 compared to previous year's Q3 of EUR 753 million.

EBIT in Global Forwarding, Freight stood at around EUR 370 million in Q3 2021, also clearly ahead of previous year's Q3 of EUR 155 million.

EBIT at Supply Chain came in at around EUR 140 million in Q3 2021, significantly above last year's Q3 result which stood at EUR 112 million.

Also, eCommerce Solutions recorded Q3 2021 EBIT of around EUR 90 million. It was at EUR 76 million in Q3 2020.

EBIT in Post & Parcel Germany in Q3 2021 was around EUR 300 million (Q3 2020: EUR 320 million).

Group Functions/Consolidation recorded a result of around EUR -105 million in Q3 2021; last year's Q3 reached EUR -39 million including positive effects in the context of the StreetScooter repositioning.

The continued positive business development is underpinned by a continued equally strong development of cash flow; free cash flow in Q3 2021 amounted to more than EUR 1.0 billion. In Q3 2020 this figure was at EUR 1.264 billion. For the first nine months of 2021 Free Cash Flow now stands at more than EUR 3.1 billion versus EUR 1.460 billion last year.

In light of the continued positive earnings momentum also in Q3 2021, management will raise guidance for FY 2021 Group EBIT and FCF, driven by the strong development in the DHL divisions. Also, the mid-term guidance for FY 2023 will be subject to upward revision.

The revised guidance will be published with the formal release of Q3 2021 earnings on November 4th 2021.

The comprehensive disclosure for Q3/9M 2021 will be released on November 4th 2021 as planned.

Financial indicators:

Explanations on these financial indicators are available in the 2020 Deutsche Post DHL Group Annual Report (see page 25f) which is published on the company's website at the link below:

Martin Ziegenbalg
EVP Investor Relations
Tel: +49 (0)228-182-63000

07-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021